Read More
Clinical trials are becoming ever more data‑driven, and your biostatistics team must adapt. The global AI-in-clinical-trials market is projected to explode (from about $2.0 B in 2024 to $22.4 B by 2034), and analysts estimate that 60–70% of trials will integrate AI tools by 2030. In practice, that means sponsors need professionals who can handle machine learning, big data, and complex ana read more..